POLE and colorectal carcinoma: (a) CpG > TpG mutations were more common at highly-methylated CpG sites in all CRC types, including MMRp, MMRd, POLE-mutant, and POLD1-mutant (P = 0.001 in all cases; JT test; Additional file 2: Figure S7A).